Veterinary Record 147:129-132 doi:10.1136/vr.147.5.129
  • Papers & Articles

Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs

  1. P. Muir, BVSc, MVetClinStud, PhD, MACVSc, MRCVS, DipACVS, DipECVS1,1
  1. 1 The Royal Veterinary College, Department of Small Animal Medicine and Surgery, Hawkshead Lane, North Mymms, AL9 7TA


The bisphosphonate drug alendronate was used to suppress bone remodelling and tumour osteolysis as a palliative treatment for two dogs with osteosarcoma, one of the tibia and one of the maxilla. A spiral fracture associated with the tibial tumour healed after it was stabilised with an external skeletal fixator. Both dogs remained comfortable and survived for 12 and 10 months respectively after diagnosis, despite the fact that neither primary tumour was resected.

    Sign up for job alerts

    Vet Record Careers features a comprehensive database of vet jobs.
    Browse for your next job, or set personalised job alerts so you hear about vacancies as soon as they go online.
    Find out more at Vet Record Careers

    Free Sample Issue

    This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of the Veterinary Record.
    View free sample issue >>

    Navigate This Article